Theratechnologies regularly receives recognition for its performance, management and employment practices.
Growth 500 - 2019
Theratechnologies has been recognized as 137th fastest growing Canadian companies over the last five years according to the 2019 Growth 500 ranking released by Canadian Business and Maclean’s.
The Growth 500 ranking is based on declared revenues over the last five completed fiscal years. For 2018, its last completed fiscal year, Theratechnologies reported revenues of
CA$ 58,533,000 compared to revenues of CA$ 7,553,000 in fiscal year 2013. This represents a 675 percent growth over the last five completed fiscal years.
TSX30 - 2019
Theratechnologies ranked 21st on the first TSX30 ranking of top performers on the Toronto Stock Exchange.
The ranking was established based on the following criteria:
• Corporate operating business listed on TSX on June 30, 2019
• Listed on TSX for a minimum of 3 years or, if a TSXV graduate, a combination of TSX and TSXV for a minimum of 3 years with at least 1 year on TSX
• Closing dividend-adjusted share price of at least $0.50 on June 30, 2016
• Minimum market cap of $50 million on June 30, 2016
A total of 583 companies qualified for the 2019 TSX30 ranking. These companies were ranked based on 3-year share price performance from June 30, 2016 to June 30, 2019.
Common shares of Theratechnologies were trading at $2.71 on June 30, 2016 and at $7.06 on June 30, 2019, representing an increase of 161% over that period.
EY Entrepreneur Of The Year™ - 2017
EY Entrepreneur Of The Year recognizes an impressive group of Quebec entrepreneurs for their financial performance, vision, leadership, personal integrity and entrepreneurial spirit.
Luc Tanguay, President and CEO of Theratechnologies, was the recipient of the 2017 Quebec Life Sciences EY Entrepreneur of the Year Award.